{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T18:24:23Z","timestamp":1765909463423,"version":"3.48.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272907, 81974397, 82170789"],"award-info":[{"award-number":["82272907, 81974397, 82170789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Big Data System Construction Project Fund of Xiangya Hospital","award":["33020125030"],"award-info":[{"award-number":["33020125030"]}]},{"name":"Hunan Provincial Science Fund for Distinguished Young Scholars","award":["2024JJ2090, 2024JJ2094"],"award-info":[{"award-number":["2024JJ2090, 2024JJ2094"]}]},{"name":"Clinical Research Foundation of the National Clinical Research Center for Geriatric Diseases","award":["2023LNJJ13, 2022LNJJ13"],"award-info":[{"award-number":["2023LNJJ13, 2022LNJJ13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06365-w","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T18:19:59Z","timestamp":1765909199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LAC-TME classifier: machine learning-driven model predicts survival and prioritizes targeted therapy in clear cell renal cell carcinoma"],"prefix":"10.1007","volume":"152","author":[{"given":"Jiawei","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"6","key":"6365_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1158\/1078-0432.CCR-14-1128","volume":"21","author":"B Beuselinck","year":"2015","unstructured":"Beuselinck B, Job S, Becht E (2015) Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting. Clin Cancer Res 21(6):1329\u20131339. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1128","journal-title":"Clin Cancer Res"},{"issue":"5","key":"6365_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE, Koehl G, Kolitzus M, Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, Kastenberger M, Bogdan C, Schleicher U, Mackensen A, Ullrich E, Fichtner-Feigl S, Kesselring R, Mack M, Ritter U, Schmid M, Blank C, Dettmer K, Oefner P, Hoffmann P, Walenta S, Geissler E, Pouyssegur J, Villunger A, Steven A, Seliger B, Schreml S, Haferkamp S, Kohl E, Karrer S, Berneburg M, Herr W, Mueller-Klieser W, Renner K, Kreutz M (2016) LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab 24(5):657\u2013671. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.011","journal-title":"Cell Metab"},{"key":"6365_CR3","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma[J]. Nature, 2013, 499(7456): 43-49. https:\/\/doi.org\/10.1038\/nature12222","DOI":"10.1038\/nature12222"},{"issue":"3","key":"6365_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo M, Tsai CH, Pucino V, Ho P-C, Mauro C (2021) Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol 21(3):151\u2013161. https:\/\/doi.org\/10.1038\/s41577-020-0406-2","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6365_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1124\/jpet.110.175786","volume":"337","author":"KF Chen","year":"2011","unstructured":"Chen KF, Chen HL, Tai WT, Feng W-C, Hsu C-H, Chen P-J, Cheng A-L (2011) Activation of phosphatidylinositol 3-kinase\/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharmacol Exp Ther 337(1):155\u2013161. https:\/\/doi.org\/10.1124\/jpet.110.175786","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"6365_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, Yao Y, Xu S, Ge S, Jia R (2025) Lactate and lactylation in cancer. Signal Transduct Target Ther 10(1):38. https:\/\/doi.org\/10.1038\/s41392-024-02082-x","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"6365_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s42255-022-00730-6","volume":"5","author":"H Cheng","year":"2023","unstructured":"Cheng H, Qiu Y, Xu Y, Chen Li, Ma K, Tao M, Frankiw L, Yin H, Xie E, Pan X, Du J, Wang Z, Zhu W, Zhang L, Li G (2023) Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness. Nat Metab 5(2):314\u2013330. https:\/\/doi.org\/10.1038\/s42255-022-00730-6","journal-title":"Nat Metab"},{"issue":"5","key":"6365_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cmet.2018.07.020","volume":"28","author":"KD Courtney","year":"2018","unstructured":"Courtney KD, Bezwada D, Mashimo T, Pichumani K, Vemireddy V, Funk AM, Wimberly J, McNeil SS, Kapur P, Lotan Y, Margulis V, Cadeddu JA, Pedrosa I, DeBerardinis RJ, Malloy CR, Bachoo RM, Maher EA (2018) Isotope tracing of human clear cell renal cell carcinomas demonstrates suppressed glucose oxidation in\u00a0vivo. Cell Metab 28(5):793-800.e2. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.020","journal-title":"Cell Metab"},{"issue":"8","key":"6365_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00345-016-1773-y","volume":"34","author":"S Dabestani","year":"2016","unstructured":"Dabestani S, Thorstenson A, Lindblad P, Harmenberg U, Ljungberg B, Lundstam S (2016) Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol 34(8):1081\u20131086. https:\/\/doi.org\/10.1007\/s00345-016-1773-y","journal-title":"World J Urol"},{"issue":"9","key":"6365_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185088","volume":"12","author":"J Dong","year":"2017","unstructured":"Dong J, Zhai B, Sun W, Hu F, Cheng H, Xu J (2017) Activation of phosphatidylinositol 3-kinase\/AKT\/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells. PLoS ONE 12(9):e0185088. https:\/\/doi.org\/10.1371\/journal.pone.0185088","journal-title":"PLoS ONE"},{"issue":"12","key":"6365_CR11","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/ijc.27604","volume":"131","author":"Z Ezzoukhry","year":"2012","unstructured":"Ezzoukhry Z, Louandre C, Tr\u00e9cherel E, Godin C, Chauffert B, Dupont S, Diouf M, Barbare JC, Mazi\u00e8re JC, Galmiche A (2012) EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib. Int J Cancer 131(12):2961\u20132969. https:\/\/doi.org\/10.1002\/ijc.27604","journal-title":"Int J Cancer"},{"issue":"9","key":"6365_CR12","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, Gottfried E, Schwarz S, Rothe G, Hoves S, Renner K, Timischl B, Mackensen A, Kunz-Schughart L, Andreesen R, Krause SW, Kreutz M (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109(9):3812\u20133819. https:\/\/doi.org\/10.1182\/blood-2006-07-035972","journal-title":"Blood"},{"issue":"6","key":"6365_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/s1074-7613(02)00323-0","volume":"16","author":"KA Frauwirth","year":"2002","unstructured":"Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, Elstrom RL, June CH, Thompson CB (2002) The CD28 signaling pathway regulates glucose metabolism. Immunity 16(6):769\u2013777. https:\/\/doi.org\/10.1016\/s1074-7613(02)00323-0","journal-title":"Immunity"},{"issue":"8","key":"6365_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002899","volume":"9","author":"A Hazini","year":"2021","unstructured":"Hazini A, Fisher K, Seymour L (2021) Deregulation of HLA-I in cancer and its central importance for immunotherapy. J Immunother Cancer 9(8):e002899. https:\/\/doi.org\/10.1136\/jitc-2021-002899","journal-title":"J Immunother Cancer"},{"issue":"10","key":"6365_CR15","doi-asserted-by":"publisher","first-page":"14015","DOI":"10.18632\/aging.203012","volume":"13","author":"W He","year":"2021","unstructured":"He W, Cheng F, Zheng B, Wang J, Zhao G, Yao Z, Zhang T (2021) NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN\/AKT\/mTOR pathway. Aging 13(10):14015\u201314038. https:\/\/doi.org\/10.18632\/aging.203012","journal-title":"Aging"},{"issue":"1","key":"6365_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V (2017) Renal cell carcinoma. Nat Rev Dis Primers 3(1):17009. https:\/\/doi.org\/10.1038\/nrdp.2017.9","journal-title":"Nat Rev Dis Primers"},{"issue":"17","key":"6365_CR17","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-14-3587","volume":"75","author":"R Hughes","year":"2015","unstructured":"Hughes R, Qian BZ, Rowan C, Muthana M, Keklikoglou I, Olson OC, Tazzyman S, Danson S, Addison C, Clemons M, Gonzalez-Angulo AM, Joyce JA, De Palma M, Pollard JW, Lewis CE (2015) Perivascular M2 macrophages stimulate tumor relapse after chemotherapy. Cancer Res 75(17):3479\u20133491. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3587","journal-title":"Cancer Res"},{"issue":"11","key":"6365_CR18","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26383","volume":"2","author":"Z Husain","year":"2013","unstructured":"Husain Z, Seth P, Sukhatme V (2013) Tumor-derived lactate and myeloid-derived suppressor cells: linking metabolism to cancer immunology. Oncoimmunology 2(11):e26383. https:\/\/doi.org\/10.4161\/onci.26383","journal-title":"Oncoimmunology"},{"issue":"2","key":"6365_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","volume":"44","author":"L Ippolito","year":"2019","unstructured":"Ippolito L, Morandi A, Giannoni E, Chiarugi P (2019) Lactate: a metabolic driver in the tumour landscape. Trends Biochem Sci 44(2):153\u2013166. https:\/\/doi.org\/10.1016\/j.tibs.2018.10.011","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"6365_CR20","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1158\/0008-5472.CAN-20-2673","volume":"81","author":"Y Kurebayashi","year":"2021","unstructured":"Kurebayashi Y, Olkowski CP, Lane KC, Vasalatiy OV, Xu BC, Okada R, Furusawa A, Choyke PL, Kobayashi H, Sato N (2021) Rapid depletion of intratumoral regulatory T cells induces synchronized CD8 T- and NK-cell activation and IFN\u03b3-dependent tumor vessel regression. Cancer Res 81(11):3092\u20133104. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-2673","journal-title":"Cancer Res"},{"key":"6365_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215885","volume":"547","author":"LE Langbein","year":"2022","unstructured":"Langbein LE, El Hajjar R, He S, Sementino E, Zhong Z, Jiang W, Leiby BE, Li L, Uzzo RG, Testa JR, Yang H (2022) BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma. Cancer Lett 547:215885. https:\/\/doi.org\/10.1016\/j.canlet.2022.215885","journal-title":"Cancer Lett"},{"issue":"1","key":"6365_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Yi, Zou Y, Wang J-X, Wang Z, Yu T (2022) Lactate metabolism in human health and disease. Signal Transduct Target Ther 7(1):305. https:\/\/doi.org\/10.1038\/s41392-022-01151-3","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"6365_CR23","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","volume":"14","author":"M Liao","year":"2024","unstructured":"Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J, Liu Bo (2024) Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharm Sin B 14(3):953\u20131008. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.003","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"6365_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-023-00844-y","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu L, Weng S, Xu H, Xing Z, Ren Y, Ge X, Wang L, Guo C, Li L, Cheng Q, Luo P, Zhang J, Han X (2023) BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data 10(1):165. https:\/\/doi.org\/10.1186\/s40537-023-00844-y","journal-title":"J Big Data"},{"issue":"7","key":"6365_CR25","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1158\/1535-7163.MCT-17-1299","volume":"17","author":"P Makhov","year":"2018","unstructured":"Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM (2018) Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies. Mol Cancer Ther 17(7):1355\u20131364. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-1299","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"6365_CR26","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","volume":"25","author":"RM Peralta","year":"2024","unstructured":"Peralta RM, Xie B, Lontos K, Nieves-Rosado H, Spahr K, Joshi S, Ford BR, Quann K, Frisch AT, Dean V, Philbin M, Cillo AR, Gingras S, Poholek AC, Kane LP, Rivadeneira DB, Delgoffe GM (2024) Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nat Immunol 25(12):2297\u20132307. https:\/\/doi.org\/10.1038\/s41590-024-01999-3","journal-title":"Nat Immunol"},{"issue":"8","key":"6365_CR27","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00018-018-2997-3","volume":"76","author":"H Prenen","year":"2019","unstructured":"Prenen H, Mazzone M (2019) Tumor-associated macrophages: a short compendium. Cell Mol Life Sci 76(8):1447\u20131458. https:\/\/doi.org\/10.1007\/s00018-018-2997-3","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"6365_CR28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","volume":"8","author":"F Shan","year":"2022","unstructured":"Shan F, Somasundaram A, Bruno TC, Workman CJ, Vignali DAA (2022) Therapeutic targeting of regulatory T cells in cancer. Trends Cancer 8(11):944\u2013961. https:\/\/doi.org\/10.1016\/j.trecan.2022.06.008","journal-title":"Trends Cancer"},{"issue":"1","key":"6365_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21387","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"6365_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"6365_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218363","volume":"21","author":"JX Wang","year":"2020","unstructured":"Wang JX, Choi SYC, Niu X, Kang N, Xue H, Killam J, Wang Y (2020) Lactic acid and an acidic tumor microenvironment suppress anticancer immunity. Int J Mol Sci 21(21):8363. https:\/\/doi.org\/10.3390\/ijms21218363","journal-title":"Int J Mol Sci"},{"issue":"7851","key":"6365_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, Menk AV, Rittenhouse NL, DePeaux K, Whetstone RD, Vignali DAA, Hand TW, Poholek AC, Morrison BM, Rothstein JD, Wendell SG, Delgoffe GM (2021) Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591(7851):645\u2013651. https:\/\/doi.org\/10.1038\/s41586-020-03045-2","journal-title":"Nature"},{"issue":"10451","key":"6365_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","volume":"404","author":"M Young","year":"2024","unstructured":"Young M, Jackson-Spence F, Beltran L, Day E, Suarez C, Bex A, Powles T, Szabados B (2024) Renal cell carcinoma. Lancet 404(10451):476\u2013491. https:\/\/doi.org\/10.1016\/S0140-6736(24)00917-6","journal-title":"Lancet"},{"issue":"6","key":"6365_CR34","doi-asserted-by":"publisher","first-page":"9377","DOI":"10.3892\/ol.2018.8536","volume":"15","author":"H Zhang","year":"2018","unstructured":"Zhang H, Wang Q, Liu J et al (2018) Inhibition of the PI3K\/Akt signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma. Oncol Lett 15(6):9377\u20139384. https:\/\/doi.org\/10.3892\/ol.2018.8536","journal-title":"Oncol Lett"},{"issue":"7","key":"6365_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012069","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Zhang M, Liu J (2025a) Mitochondrial pathway signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer 13(7):e012069. https:\/\/doi.org\/10.1136\/jitc-2025-012069","journal-title":"J Immunother Cancer"},{"issue":"1","key":"6365_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mdr2.70004","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, Yu F, Li L, Huang R, Zhang P, Kadier K, Wang Y, Gu Q, Ding Y, Gu T, Chi H, Zhang S, Wu R, Xu Y, Zhu S, Zheng H, Zhao T, He Qi, Qiu X (2025b) Optimized dynamic network biomarker deciphers a high\u2010resolution heterogeneity within thyroid cancer molecular subtypes. Med Res 1(1):10\u201331. https:\/\/doi.org\/10.1002\/mdr2.70004","journal-title":"Med Res"},{"issue":"14","key":"6365_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI180080","volume":"134","author":"L Zhou","year":"2024","unstructured":"Zhou L, Velegraki M, Wang Y, Mandula JK, Chang Y, Liu W, Song N-J, Kwon H, Xiao T, Bolyard C, Hong F, Xin G, Ma Q, Rubinstein MP, Wen H, Li Z (2024) Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy. J Clin Invest 134(14):e180080. https:\/\/doi.org\/10.1172\/JCI180080","journal-title":"J Clin Invest"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06365-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06365-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06365-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T18:20:00Z","timestamp":1765909200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06365-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6365"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06365-w","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study utilized publicly available datasets from The Cancer Genome Atlas (TCGA), E-MTAB-1980, and The Human Protein Atlas. As these datasets are publicly accessible and do not contain any personally identifiable information, ethics approval was not required. The study adhered to all relevant guidelines for the use of publicly available data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"10"}}